AGL Stock Overview
Provides healthcare services for seniors through primary care physicians in the communities of the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
agilon health, inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.57 |
| 52 Week High | US$13.76 |
| 52 Week Low | US$1.50 |
| Beta | 0.60 |
| 11 Month Change | -47.32% |
| 3 Month Change | -66.09% |
| 1 Year Change | -86.37% |
| 33 Year Change | -93.22% |
| 5 Year Change | n/a |
| Change since IPO | -94.94% |
Recent News & Updates
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Recent updates
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Oct 15agilon health: Interesting Business Model, But Volatile And Uncertain
Aug 16Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Aug 16Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Jul 15The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28Shareholder Returns
| AGL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -27.3% | -5.1% | -2.1% |
| 1Y | -86.4% | 3.0% | 29.7% |
Return vs Industry: AGL underperformed the US Healthcare industry which returned 2.9% over the past year.
Return vs Market: AGL underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| AGL volatility | |
|---|---|
| AGL Average Weekly Movement | 15.8% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AGL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AGL's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 1,117 | Steve Sell | www.agilonhealth.com |
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021.
agilon health, inc. Fundamentals Summary
| AGL fundamental statistics | |
|---|---|
| Market cap | US$650.99m |
| Earnings (TTM) | -US$310.98m |
| Revenue (TTM) | US$5.59b |
0.1x
P/S Ratio-2.1x
P/E RatioIs AGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGL income statement (TTM) | |
|---|---|
| Revenue | US$5.59b |
| Cost of Revenue | US$5.65b |
| Gross Profit | -US$51.77m |
| Other Expenses | US$259.21m |
| Earnings | -US$310.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.75 |
| Gross Margin | -0.93% |
| Net Profit Margin | -5.56% |
| Debt/Equity Ratio | 6.1% |
How did AGL perform over the long term?
See historical performance and comparison